Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospital groups weigh in on MIRA

This article was originally published in The Gray Sheet

Executive Summary

Payments for hospital services would be cut to divert resources to medical technology as a consequence of the "Medicare Innovation Responsiveness Act" of 2003 (HR 941), due to the budget-neutral nature of Medicare, the American Hospital Association and Federation of American Hospitals maintain. In a June 6 letter to bill co-sponsor Jim Ramstad (R-Minn.) and other members of the House Ways & Means Committee, the groups add that rural hospitals would be particularly hard-hit because they "are typically the last to adopt technological innovations, largely because there are few specialists and tertiary facilities in rural areas." The committee is evaluating whether to incorporate MIRA into Medicare reform legislation expected to be unveiled in the next several weeks...

You may also be interested in...



Ways & Means Drug Bill Provides Vehicle For MIRA Coverage, Coding Reforms

House lawmakers are still working to persuade hospital groups that new technology provisions included in the "Medicare Prescription & Modernization Act" of 2003 will not have a detrimental effect on hospital services

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel